Some of our team in Immunology and PRU have had an article published in the Annals of Clinical Biochemistry. The article looks at how one of the newest myeloma drugs interfered with monitoring of a myeloma patient at the St George’s Hospital.
Multiple myeloma is a haematological cancer caused by malignant plasma cells in the bone marrow that can result in organ dysfunction and death. This patient was treated with isatuximab, a newly approved treatment for myeloma, which prevented demonstration of complete remission.
The paper was authored by Consultant Clinical Scientists Dr Rachel Wheeler, Dr Sarah Linstead and Joanne Morris and Biomedical Scientists Micsha Costa and Asante Crichlow, along with St George’s haematology Consultants Dr Fenella Willis and Dr Yasmin Reyal.